Search research articles
Contact Us
Filters
Showing results (141-150 of 221) with videos related to
Page
of 23
Sort By:
Plos One
|
May 30, 2013
Decreased microRNA is involved in the vascular remodeling abnormalities in chronic kidney disease (CKD)
Neal X Chen, Kraiwiporn Kiattisunthorn, Kalisha D O'Neill, et al.
Bone
|
February 4, 2024
A comprehensive set of ultrashort echo time magnetic resonance imaging biomarkers to assess cortical bone health: A feasibility study at clinical field strength
Andrea M Jacobson, Xuandong Zhao, Stefan Sommer, et al.
Bone
|
April 28, 2019
Short-term pharmacologic RAGE inhibition differentially affects bone and skeletal muscle in middle-aged mice
Hannah M Davis, Alyson L Essex, Sinai Valdez, et al.
Clinical Oral Investigations
|
October 9, 2013
A novel approach to evaluate the effect of medicaments used in endodontic regeneration on root canal surface indentation
Ghaeth H Yassen, Tien-Min G Chu, Maxime A Gallant, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
November 20, 2014
Anti-sclerostin antibody treatment in a rat model of progressive renal osteodystrophy
Sharon M Moe, Neal X Chen, Christopher L Newman, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
October 27, 2011
Cell autonomous requirement of connexin 43 for osteocyte survival: consequences for endocortical resorption and periosteal bone formation
Nicoletta Bivi, Keith W Condon, Matthew R Allen, et al.
Physiological Reports
|
June 2, 2020
Erythropoietin and a hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHDi) lowers FGF23 in a model of chronic kidney disease (CKD)
Megan L Noonan, Erica L Clinkenbeard, Pu Ni, et al.
Bone Reports
|
March 7, 2022
Cortical porosity is elevated after a single dose of zoledronate in two rodent models of chronic kidney disease
Elizabeth A Swallow, Corinne E Metzger, Neal X Chen, et al.
Bone
|
July 23, 2013
In vivo reference point indentation reveals positive effects of raloxifene on mechanical properties following 6 months of treatment in skeletally mature beagle dogs
Mohammad Aref, Maxime A Gallant, Jason M Organ, et al.
American Journal of Nephrology
|
February 17, 2016
Calcitriol Suppression of Parathyroid Hormone Fails to Improve Skeletal Properties in an Animal Model of Chronic Kidney Disease
Christopher L Newman, Nannan Tian, Max A Hammond, et al.
Page
of 23
Search research articles
Search
Showing results (141-150 of 221) with videos related to
Sort By:
Page
of 23
Plos One
|
May 30, 2013
Decreased microRNA is involved in the vascular remodeling abnormalities in chronic kidney disease (CKD)
Neal X Chen, Kraiwiporn Kiattisunthorn, Kalisha D O'Neill, et al.
Bone
|
February 4, 2024
A comprehensive set of ultrashort echo time magnetic resonance imaging biomarkers to assess cortical bone health: A feasibility study at clinical field strength
Andrea M Jacobson, Xuandong Zhao, Stefan Sommer, et al.
Bone
|
April 28, 2019
Short-term pharmacologic RAGE inhibition differentially affects bone and skeletal muscle in middle-aged mice
Hannah M Davis, Alyson L Essex, Sinai Valdez, et al.
Clinical Oral Investigations
|
October 9, 2013
A novel approach to evaluate the effect of medicaments used in endodontic regeneration on root canal surface indentation
Ghaeth H Yassen, Tien-Min G Chu, Maxime A Gallant, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
November 20, 2014
Anti-sclerostin antibody treatment in a rat model of progressive renal osteodystrophy
Sharon M Moe, Neal X Chen, Christopher L Newman, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
October 27, 2011
Cell autonomous requirement of connexin 43 for osteocyte survival: consequences for endocortical resorption and periosteal bone formation
Nicoletta Bivi, Keith W Condon, Matthew R Allen, et al.
Physiological Reports
|
June 2, 2020
Erythropoietin and a hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHDi) lowers FGF23 in a model of chronic kidney disease (CKD)
Megan L Noonan, Erica L Clinkenbeard, Pu Ni, et al.
Bone Reports
|
March 7, 2022
Cortical porosity is elevated after a single dose of zoledronate in two rodent models of chronic kidney disease
Elizabeth A Swallow, Corinne E Metzger, Neal X Chen, et al.
Bone
|
July 23, 2013
In vivo reference point indentation reveals positive effects of raloxifene on mechanical properties following 6 months of treatment in skeletally mature beagle dogs
Mohammad Aref, Maxime A Gallant, Jason M Organ, et al.
American Journal of Nephrology
|
February 17, 2016
Calcitriol Suppression of Parathyroid Hormone Fails to Improve Skeletal Properties in an Animal Model of Chronic Kidney Disease
Christopher L Newman, Nannan Tian, Max A Hammond, et al.
Page
of 23